(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Blocking the cardiac cell cycle results in loss of early, but not late,
cardiac markers. (A) Cardiac explants isolated and cultured in DMSO
or aphidicolin to block cells in S phase beginning at stage 22 and fixed at
stage 37. Whole-mount immunostaining of explants with phosphohistone
H3-specific antibody (red). In situ hybridization on explants with the early
cardiac markers (B) Tbx5, Tbx20, Nkx2.5, (C) Gata4,
Gata5 and Gata6, (D) with the cardiac differentiation
markers Hsp27 and MLC1v', and (E) by
whole-mount immunostaining with the cardiac differentiation markers Tmy and
MHC. (F) Explants were treated with DMSO or colchicine (Colch) to block
cells in M phase of the cell cycle. In situ hybridization was performed to
examine expression of Tbx5, Nkx2.5 and MLC1V', as
indicated. Aph, aphidicolin; BF, bright field; pH3, phosphohistone H3-specific
antibody.